
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Naringin is a flavanone glycoside primarily found in citrus fruits that supports cardiovascular health by modulating lipid metabolism and reducing arterial stiffness. It works through activation of AMP-activated protein kinase (AMPK) pathways and inhibition of HMG-CoA reductase enzyme activity.

Origin & History

Naringin is a flavanone glycoside naturally abundant in citrus fruits including grapefruit, oranges (Citrus sinensis), bergamot, and tomatoes. It is typically extracted from citrus peels or whole fruit using solvent extraction methods, and occurs in standardized whole-orange extracts used in clinical studies.
Research Narrative (Provisional)
Human clinical evidence is limited, with most data from a single-ascending-dose trial (PMID: 31468636) testing 150-900mg naringenin from whole-orange extract in healthy adults, showing peak serum concentrations of 43.11 μM at 4 hours with no serious adverse events. Additional small trials report benefits on lipid profiles and arterial stiffness (PMIDs: 40871686, 39352635), while a phase I trial (NCT01091077) investigated 1g naringenin for HCV inhibition and vLDL reduction.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Naringin (naringenin-7-O-neohesperidoside; C₂₇H₃₂O₁₄; MW 580.53 g/mol) is a flavanone glycoside, not a macronutrient source — it provides negligible calories, protein, fat, or fiber. Its significance is entirely as a bioactive polyphenolic compound. Key profile details: • Primary bioactive compound: Naringin itself, typically found at 100–600 mg per liter of grapefruit juice; whole grapefruit peel and albedo contain 2–10% naringin by dry weight. Pomelo peel can contain up to 15–20% by dry weight. • Aglycone (active metabolite): Naringenin (MW 272.26 g/mol), released by intestinal bacterial hydrolysis of the rhamnose-glucose disaccharide (neohesperidose) moiety. Naringenin is the principal absorbed form. • Bioavailability: Oral bioavailability of intact naringin is low (~5–8% in animal models). Absorption depends heavily on colonic microflora (e.g., Bacteroides spp.) cleaving the sugar moiety to yield naringenin, which is then absorbed and undergoes extensive phase II hepatic conjugation (glucuronidation and sulfation). Peak plasma concentrations of total naringenin metabolites after 500 mg oral naringin typically reach ~1–6 µmol/L (Tmax ~3–6 hours). Enteric recycling extends the elimination half-life to approximately 2–3 hours for naringenin conjugates. • Key micronutrient co-occurrence (when consumed via whole grapefruit): Vitamin C (~38 mg per fruit), potassium (~166 mg per 100 g), folate (~13 µg per 100 g), dietary fiber (~1.6 g per 100 g), and co-occurring flavonoids including hesperidin, narirutin, and furanocoumarins (bergamottin, 6',7'-dihydroxybergamottin — relevant to CYP3A4/CYP1A2 inhibition and drug interactions). • Other polyphenolic co-constituents in citrus matrix: Hydroxycinnamic acids (ferulic acid, p-coumaric acid), limonoids (limonin ~5–30 mg/L in juice), and carotenoids (β-cryptoxanthin, lycopene in pink/red grapefruit). • Supplemental dosing context: Human clinical trials (e.g., NCT01091077) have used 150–900 mg/day of purified naringin. Commercial supplements typically provide 500 mg per capsule of naringin extract (≥95% purity). • Solubility and formulation notes: Naringin has limited water solubility (~1 mg/mL at 25°C), contributing to its poor bioavailability. Naringin complexed with cyclodextrins or delivered as phospholipid complexes (phytosomes) can improve absorption 2–4 fold. Nanoformulations under investigation report up to 6-fold bioavailability enhancement in preclinical models. • Caloric/macronutrient contribution: Essentially zero at supplemental doses; when consumed via grapefruit (per 100 g raw): ~42 kcal, 0.77 g protein, 0.14 g fat, 10.7 g carbohydrate, 1.6 g fiber.
Reported Mechanism (Provisional)
Naringin activates AMP-activated protein kinase (AMPK) signaling pathways, which enhances fatty acid oxidation and glucose uptake. It inhibits HMG-CoA reductase enzyme activity, reducing cholesterol synthesis, while also modulating PPAR-γ receptors to improve adiponectin production. Additionally, naringin exhibits antioxidant properties by scavenging reactive oxygen species and upregulating endogenous antioxidant enzymes like superoxide dismutase.
Clinical Narrative (Provisional)
Clinical reviews show moderate evidence for cardiovascular protection in hypercholesterolemic and overweight patients, though sample sizes remain limited. Phase I trial NCT01091077 demonstrated preliminary improvements in lipid profiles, including reduced vLDL cholesterol levels. Limited human trials suggest enhanced arterial stiffness markers and increased adiponectin levels, but larger randomized controlled trials are needed to confirm therapeutic efficacy. Current evidence is promising but requires additional robust clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







